{"disease":{"id":"hcc","name":"hcc"},"drugs":{"marketed":[{"drug_id":"chembl-chembl3301587","indication_name":"Unresectable HCC","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"DURVALUMAB","company_name":"","drug_phase":"marketed","molecular_target":"PD-L1","drug_class":"Programmed Death Ligand-1 Blocker [EPC]","quality_score":10,"revenue":null,"mechanism":"Durvalumab binds to PD-L1, blocking its interaction with PD-1 and CD80, enhancing T-cell activation and reducing tumor size."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03047369","title":"The Myelin Disorders Biorepository Project","phase":"","overall_status":"RECRUITING","enrollment_count":12000,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":false},{"nct_id":"NCT07153783","title":"Interventional AI-Human Collaboration for Liver Tumor Diagnosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":10333,"lead_sponsor_name":"Shengjing Hospital","has_results":false},{"nct_id":"NCT07157085","title":"AI Multitask Model for HCC Treatment","phase":"","overall_status":"COMPLETED","enrollment_count":7000,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT04371042","title":"PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT05965388","title":"Predictive Value of HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated With Antiviral Therapy","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Wen-hong Zhang","has_results":false},{"nct_id":"NCT06008548","title":"A New Conception About Individualized Treatment Allocation for HCC","phase":"","overall_status":"COMPLETED","enrollment_count":4991,"lead_sponsor_name":"Tang-Du Hospital","has_results":false},{"nct_id":"NCT06621485","title":"Calculator Predicts Early Mortality Post Hepatocellular Carcinoma Resection","phase":"","overall_status":"COMPLETED","enrollment_count":4966,"lead_sponsor_name":"Beijing Tsinghua Chang Gung Hospital","has_results":false},{"nct_id":"NCT07010198","title":"Head-to-Head Comparison of Hepatocellular Cancer (HCC) Screening Strategies: A Prospective Population-Based Cohort Study in Zhongshan City","phase":"","overall_status":"RECRUITING","enrollment_count":4500,"lead_sponsor_name":"Zhongshan People's Hospital, Guangdong, China","has_results":false},{"nct_id":"NCT04530240","title":"Equity and Efficacy of Allocation Priority for Liver Transplantation Patients With MELD≥30 in Italy","phase":"","overall_status":"COMPLETED","enrollment_count":4238,"lead_sponsor_name":"University of Bologna","has_results":false},{"nct_id":"NCT06776185","title":"Recurrence Patterns and Cost-Effectiveness of Surgical Approaches in Early-Stage Hepatocellular Carcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":3000,"lead_sponsor_name":"Chen Xiaoping","has_results":false},{"nct_id":"NCT07368530","title":"Using Machine Learning to Identify Responders to TACE or HAIC for uHCC","phase":"","overall_status":"COMPLETED","enrollment_count":3000,"lead_sponsor_name":"First Affiliated Hospital, Sun Yat-Sen University","has_results":false},{"nct_id":"NCT03884062","title":"Clinical Impacts of Achieving SVR in Patients With Advanced Hepatic Fibrosis Related to Chronic HCV Treated With Direct Acting Antivirals","phase":"","overall_status":"COMPLETED","enrollment_count":3000,"lead_sponsor_name":"Egyptian Liver Hospital","has_results":false},{"nct_id":"NCT07156617","title":"A Study on the Heterogeneity of Efficacy of Interventional Therapy Combined With Systemic Therapy for Liver Cancer Based on Multi-center Real-world Data","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Xuhua Duan","has_results":false},{"nct_id":"NCT07038863","title":"Community Screening and Management of Hepatitis B, C and Delta in the Mongolian Population Living in France","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT06799468","title":"Validation of the TRAIN-AI for the Risk of HCC Recurrence After Liver Transplantation","phase":"","overall_status":"COMPLETED","enrollment_count":1769,"lead_sponsor_name":"European Hepatocellular Cancer Liver Transplant Group","has_results":false},{"nct_id":"NCT07444905","title":"Prospective Evaluation of a Locked Risk-Stratified Surveillance Strategy for Extrahepatic Metastasis in Hepatocellular Carcinoma","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1523,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT05176483","title":"Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":1314,"lead_sponsor_name":"Exelixis","has_results":false},{"nct_id":"NCT06881446","title":"Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/tyrosine Kinase Inhibitors with or Without TACE for Advanced HCC with Vascular Invasions","phase":"","overall_status":"RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Zhongda Hospital","has_results":false},{"nct_id":"NCT06637059","title":"Artificially Intelligent Model for Accurate Detection of HCC","phase":"","overall_status":"COMPLETED","enrollment_count":1092,"lead_sponsor_name":"Zhejiang University","has_results":false},{"nct_id":"NCT07481032","title":"Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":1034,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT06806579","title":"Atezolizumab-bevacizumab and Other Immunotherapies: Real-life Experience for Treatment of Hepatocellular Carcinoma","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT07417800","title":"Construction and Clinical Validation of a Predictive Model for Postoperative Adjuvant Therapy in Hepatocellular Carcinoma Based on Whole-Slide Digital Pathological Images and Deep Learning","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT07272200","title":"Understanding Gene ENvironment Interaction in ALcohol-related Hepatocellular Carcinoma","phase":"NA","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","has_results":false},{"nct_id":"NCT06774768","title":"Use of Machine-learning Algorithms, Biomarkers and Measures of Quality of Life to Personalize Medical Management of Liver and Heart Transplant Recipients","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT07224750","title":"A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT01761266","title":"A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-line Treatment of Participants With Unresectable Hepatocellular Carcinoma","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":954,"lead_sponsor_name":"Eisai Limited","has_results":true},{"nct_id":"NCT06663904","title":"Different Abbreviated MRI for Hepatocellular Carcinoma Diagnosis","phase":"","overall_status":"COMPLETED","enrollment_count":938,"lead_sponsor_name":"First Affiliated Hospital, Sun Yat-Sen University","has_results":false},{"nct_id":"NCT06842563","title":"Hepatocellular Carcinoma 3 Gene Methylation Combination Detection Kit (PCR Fluorescent Probe Method) Multicenter Clinical Trial","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":900,"lead_sponsor_name":"Singlera Genomics Inc.","has_results":false},{"nct_id":"NCT06881433","title":"Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/tyrosine Kinase Inhibitors with or Without HAIC for Advanced HCC","phase":"","overall_status":"RECRUITING","enrollment_count":900,"lead_sponsor_name":"Zhongda Hospital","has_results":false},{"nct_id":"NCT04539717","title":"FAST (Focused Abbreviated Screening Technique)-MRI Study","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":820,"lead_sponsor_name":"Icahn School of Medicine at Mount Sinai","has_results":false},{"nct_id":"NCT07109336","title":"Development and Prospective Validation of a Heterogeneous Treatment Effect-Based Decision Model for Transarterial Chemoembolization Combined With or Without Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":790,"lead_sponsor_name":"Zhongda Hospital","has_results":false},{"nct_id":"NCT06864195","title":"A Simple Breath Test to Detect Liver Cancer and Monitor Liver Conditions","phase":"","overall_status":"RECRUITING","enrollment_count":750,"lead_sponsor_name":"Imperial College London","has_results":false},{"nct_id":"NCT06923176","title":"Effect of Biejia-Ruangan Compound on Survival Rate and Recurrence Rate of Hepatocellular Carcinoma After Radical Treatment","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":704,"lead_sponsor_name":"Zhiyun Yang","has_results":false},{"nct_id":"NCT07141056","title":"The Impact of Emotional Stress on Immunotherapy Outcomes in Liver Cancer Patients: A Multi-Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":700,"lead_sponsor_name":"Guilin Medical University, China","has_results":false},{"nct_id":"NCT04639180","title":"A Study to Evaluate Camrelizumab Plus Rivoceranib (Apatinib) as Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":687,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT03412773","title":"A Study of Tislelizumab Versus Sorafenib in Participants With Unresectable Hepatocellular Carcinoma (HCC)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":684,"lead_sponsor_name":"BeiGene","has_results":true},{"nct_id":"NCT07490262","title":"A Study to Evaluate the Efficacy and Safety of IBI310 and Sintilimab Combination Therapy in Patients With Hepatocellular Carcinoma as First-line Treatment.","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":680,"lead_sponsor_name":"Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.","has_results":false},{"nct_id":"NCT06841185","title":"A Study to Compare the Efficacy, Safety, Immunogenicity, and Pharmacokinetic Profile of HLX13 with YERVOY As a First-Line Treatment for Patients with Unresectable Hepatocellular Carcinoma","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":656,"lead_sponsor_name":"Shanghai Henlius Biotech","has_results":false},{"nct_id":"NCT05720195","title":"ALBI and PALBI Scores and HCC Prognosis","phase":"","overall_status":"COMPLETED","enrollment_count":645,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT06461936","title":"Intra-Tumoral Vascular Growth Patterns is a Robust Indicator of Adjuvant Therapy Following Liver Resection in HCC","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":620,"lead_sponsor_name":"Chen Xiaoping","has_results":false},{"nct_id":"NCT07469319","title":"Biannual Screening for HCC Offered to Patients With Cirrhosis. Introducing Surveillance for Hepatocellular Carcinoma (HCC) in the Central Denmark Region Using Ultrasound and Alpha-Fetoprotein to Reduce HCC-Related Mortality in Patients With Compensated Non-Viral Cirrhosis","phase":"NA","overall_status":"RECRUITING","enrollment_count":617,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT06184152","title":"CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules","phase":"NA","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"University of Texas Southwestern Medical Center","has_results":false},{"nct_id":"NCT07265271","title":"A Cell-free tsRNA Signature for Early Detection of Hepatocellular Carcinoma","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT05919264","title":"FOG-001 in Locally Advanced or Metastatic Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":595,"lead_sponsor_name":"Parabilis Medicines, Inc.","has_results":false},{"nct_id":"NCT07030842","title":"Precision Recurrence Risk Assessment in Early-stage Hepatocellular Carcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":579,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT07321613","title":"Effect of TCC Cocktail Combined With TACE Versus TACE Alone on Survival in uHCC Patients","phase":"","overall_status":"COMPLETED","enrollment_count":545,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT03764293","title":"A Study to Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCC","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":543,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":true},{"nct_id":"NCT05637788","title":"Artificial Intelligence and Hepatocellular Carcinoma","phase":"","overall_status":"UNKNOWN","enrollment_count":535,"lead_sponsor_name":"Humanitas Clinical and Research Center","has_results":false},{"nct_id":"NCT04523493","title":"Phase III Study of Toripalimab（JS001） Combined With Lenvatinib for Advanced HCC","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":530,"lead_sponsor_name":"Shanghai Junshi Bioscience Co., Ltd.","has_results":false},{"nct_id":"NCT02188901","title":"Contrast (Sonazoid)-Enhanced US as a Screening Tool for Hepatocellular Carcinoma in Cirrhosis: An Exploratory Cross-sectional Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":523,"lead_sponsor_name":"Yonsei University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}